Iizuka, et al.-Chem. Abst., vol. 77 (1972) p. 17315u. |
Korninger et al.-Chem. Abst., vol. 95 (1981) p. 197233u. |
Belousov, et al.-Chem. Abst., vol. 92 (1980) p. 39285w. |
Lawrence K. Altman, The New York Times, "Protein of Cancer Cells Used to Halt Coronaries", Nov. 16, 1983. |
Eugene G. Levin, Proc. Natl. Acad. Sci. USA, "Latent Tissue Plasminogen Activator Produced by Human Endothelial Cells in Culture: Evidence for an Enzyme-Inhibitor Complex", Nov. 1983, vol. 80, pp. 6804-6808. |
Frans van de Werf, et al., The New England Journal of Medicine, "Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction", Mar. 8, 1984, vol. 310, No. 10, pp. 609-613. |
Keith A. A. Fox, et al., Biochemical Pharmacology, Commentary, "Coronary Thrombolysis: Pharmacological Considerations with Emphasis on Tissue-Type Plasminogen Activator" (t-PA), 1984, vol. 33, No. 12, pp. 1831-1838. |